ArticleCardiovascular research2017

A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Chahua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.